Heart scan trial aims to shield cancer patients from hidden risk
NCT ID NCT05879913
Summary
This study is testing if a special heart scan can help personalize treatment to reduce heart disease risk in men with prostate cancer who are on hormone therapy. Researchers will compare patients who get the scan and tailored treatment to those who receive usual care. The goal is to see if this approach better identifies and manages hidden heart risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IU Health Joe and Shelly Schwarz Cancer Center
RECRUITINGCarmel, Indiana, 46032, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Methodist Hospital
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.